Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Will Republican Takeover Of House Slow 510(k) Reforms?

This article was originally published in The Gray Sheet

Executive Summary

The shift to Republican leadership in the House following the Nov. 2 election means the device industry will find a more sympathetic ear in Congress on 510(k) reforms and reauthorization of medical device user fees, device policy insiders say.

You may also be interested in...



Device Industry Friend To Head Energy And Commerce Panel

Michigan Republican Fred Upton, the incoming House Energy and Commerce Committee Chairman, is well-informed on health care and medical device policy issues, and likely will be an industry-friendly force in the 112th Congress, industry reps say.

Device Industry Friend To Head Energy And Commerce Panel

Michigan Republican Fred Upton, the incoming House Energy and Commerce Committee Chairman, is well-informed on health care and medical device policy issues, and likely will be an industry-friendly force in the 112th Congress, industry reps say.

Senate Bill In The Works For Laboratory-Developed Tests

Sen. Orrin Hatch, R-Utah, is developing a bill that would create a new pre-market review process for laboratory-developed tests, even as FDA plans to pursue such oversight without legislation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029582

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel